Life Technologies' New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
Published: Sep 20, 2012
CARLSBAD, Calif. and BEIJING, Sept. 19, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE), a world-leading biotechnology company, today announced the completion of a state-of-the-art facility in Beijing where the most advanced DNA testing solutions will be manufactured and readily available to help forensics labs and law enforcement agencies solve crimes more cost effectively in China.
DNA testing kits manufactured in China such as Life Technologies' newly released GlobalFiler, will offer forensics labs rapid access to the world's leading human identification (HID) technology.
"China continues to be a key growth market for Life Technologies as we continue to expand our operations and product offerings across the country," said Gregory T. Lucier, Chairman and CEO of Life Technologies. "According to the Ministry of Science and Technology, biotech is a strategic and emerging industry for China and our investment in this state-of-the-art manufacturing facility is another example of our on-going commitment to support our Chinese forensic partners in new and expanded ways."
Life Technologies has been instrumental in supporting efforts in China to create one of the largest DNA database in the world. More than 400 crime labs in the country have implemented database programs with a combined offender sample pool of 15 million. Under the guidance of the Ministry of Public Security, China has secured its place as a world leader in utilizing DNA testing as a primary tool to fight crime.
For more than 25 years, Life Technologies has led the development and commercialization of the industry's most trusted and reliable forensic solutions for HID testing. Life is also the only company in the world that designs and validates its reagents, instruments and data analysis software together as an integrated system for HID testing.
"Public safety plays a critical role as the Chinese government takes steps to build a harmonious society," said Dr. Siddhartha Kadia, President of Life Technologies, Greater China. "Our goal is to quickly respond to the demands of our Chinese customers, and we have met that challenge by providing them with locally manufactured, cutting-edge DNA testing tools to support crime fighting in the country more effectively."
For more information, visit Life Technologies' HID website.
GlobalFiler is for forensic or paternity use only.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today's most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum with more than 50,000 products for agricultural biotechnology, translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent, Applied Biosystems®, Invitrogen, GIBCO®, Ambion®, Molecular Probes®, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011. Visit us at our website: www.lifetechnologies.com.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Life Technologies Contact
SOURCE Life Technologies Corporation